Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8055.7%
5Y CAGR+1497.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+8055.7%/yr
vs +12.2%/yr prior
5Y CAGR
+1497.3%/yr
Recent acceleration
Acceleration
+8043.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1039769.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $25.66T | +53214965.1% |
| 2024 | $48.22M | +63.7% |
| 2023 | $29.46M | -37.7% |
| 2022 | $47.31M | +5.3% |
| 2021 | $44.94M | +82.1% |
| 2020 | $24.68M | -44.4% |
| 2019 | $44.35M | +48.7% |
| 2018 | $29.82M | +82.9% |
| 2017 | $16.30M | +23.7% |
| 2016 | $13.18M | - |